ES2130138T3 - Derivado de xantina. - Google Patents

Derivado de xantina.

Info

Publication number
ES2130138T3
ES2130138T3 ES91917824T ES91917824T ES2130138T3 ES 2130138 T3 ES2130138 T3 ES 2130138T3 ES 91917824 T ES91917824 T ES 91917824T ES 91917824 T ES91917824 T ES 91917824T ES 2130138 T3 ES2130138 T3 ES 2130138T3
Authority
ES
Spain
Prior art keywords
represents hydrogen
different
xantina
derivative
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917824T
Other languages
English (en)
Inventor
Fumio Suzuki
Junichi Shimada
Akio Ishii
Hiromi Nonaka
Nobuo Kosaka
Shunji Hita Ichikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of ES2130138T3 publication Critical patent/ES2130138T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Led Devices (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

UN NUEVO DERIVADO DE LA XANTINA REPRESENTADO POR LA FORMULA GENERAL (I), QUE ANTAGONIZA SELECTIVAMENTE AL RECEPTOR DE ADENOSINA Y UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO. EN LA FORMULA (I) R1 Y R2 PUEDEN SER IGUALES O DIFERENTES Y CADA UNO REPRESENTA HIDROGENO, PROPILO, BUTILO O ALILO; R3 REPRESENTA HIDROGENO O ALQUILO INFERIOR; Y1 Y Y2 PUEDEN SER IGUALES O DIFERENTES Y CADA UNO REPRESENTA HIDROGENO O METILO; Y Z REPRESENTA FENILO (IN)SUSTITUIDO, PIRIDILO, IMIDAZOLILO, FURILO O TIENILO.
ES91917824T 1990-10-18 1991-10-17 Derivado de xantina. Expired - Lifetime ES2130138T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28017190 1990-10-18

Publications (1)

Publication Number Publication Date
ES2130138T3 true ES2130138T3 (es) 1999-07-01

Family

ID=17621294

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917824T Expired - Lifetime ES2130138T3 (es) 1990-10-18 1991-10-17 Derivado de xantina.

Country Status (6)

Country Link
EP (1) EP0559893B1 (es)
AT (1) ATE176470T1 (es)
CA (1) CA2094270C (es)
DE (1) DE69130869T2 (es)
ES (1) ES2130138T3 (es)
WO (1) WO1992006976A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
CA2093403C (en) * 1992-04-08 1999-08-10 Fumio Suzuki Therapeutic agent for parkinson's disease
CA2116967C (en) * 1992-07-08 2003-08-19 Fumio Suzuki Antidepressants
TW252044B (es) * 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
CA2112031A1 (en) * 1992-12-24 1994-06-25 Fumio Suzuki Xanthine derivatives
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
DE69526822T2 (de) * 1994-02-23 2003-01-23 Kyowa Hakko Kogyo K.K., Tokio/Tokyo Xanthin-derivate
DE69834500T2 (de) 1997-09-05 2007-05-03 Kyowa Hakko Kogyo Co., Ltd. Xanthinderivative zur behandlung von hirnischämie
CA2315736A1 (en) 1998-01-05 1999-07-15 Eisai Co., Ltd. Purine compounds and adenosine a2 receptor antagonist as preventive or therapeutic for diabetes mellitus
ATE319452T1 (de) * 1999-10-29 2006-03-15 Kyowa Hakko Kogyo Kk Arzneimittel gegen essstörungen
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
ES2686123T3 (es) 2002-01-28 2018-10-16 Kyowa Hakko Kogyo Co., Ltd Antagonistas del receptor A2A para su uso en el tratamiento de trastornos del movimiento
US20060122198A1 (en) * 2003-06-27 2006-06-08 Kyowa Hakko Kogyo Co., Ltd. Antiepileptic agent
CA2554426C (en) 2004-01-28 2012-10-16 Kyowa Kirin Co., Ltd. Agents for treating migraine
ES2273599B1 (es) 2005-10-14 2008-06-01 Universidad De Barcelona Compuestos para el tratamiento de la fibrilacion auricular.
CA2670788A1 (en) * 2006-12-01 2008-06-12 Cv Therapeutics, Inc. A2a adenosine receptor antagonists
MX2009006346A (es) * 2006-12-22 2010-03-03 Sanol Arznei Schwarz Gmbh Derivados de 8-etinilxantina como antagonistas de receptores de a2a selectivos.
RU2477726C1 (ru) * 2011-10-18 2013-03-20 Общество С Ограниченной Ответственностью "Ньювак" (Ооо "Ньювак") Замещенные феноксиуксусные кислоты, их эфиры и амиды, включающие 2,6-диоксо-2,3,6,7-тетрагидро-1н-пурин-8-иловый фрагмент, - антагонисты аденозинового a2a рецептора и их применение
CN110981876B (zh) * 2018-12-21 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111072663B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途
CN111018856B (zh) * 2019-12-12 2021-10-01 广东东阳光药业有限公司 8-取代的苯乙烯基黄嘌呤衍生物及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2988711B2 (ja) * 1989-10-20 1999-12-13 協和醗酵工業株式会社 縮合プリン誘導体

Also Published As

Publication number Publication date
WO1992006976A1 (en) 1992-04-30
ATE176470T1 (de) 1999-02-15
CA2094270A1 (en) 1992-04-19
DE69130869T2 (de) 1999-06-10
CA2094270C (en) 1997-01-21
EP0559893A4 (en) 1994-07-06
DE69130869D1 (en) 1999-03-18
EP0559893B1 (en) 1999-02-03
EP0559893A1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
DE69130869D1 (en) Xanthinderivate
DK0784974T3 (da) Fremstilling af xanthinderivater i fast dispersion
DE69628804D1 (de) Substitutierte heterozyclische Derivate als CRF Antagonisten
DE69839735D1 (de) Pyrimidin-5-carboxamid-derivate
PT1022277E (pt) Novos derivados de taxano
HUT47789A (en) Compositions containing n-/dihalogeno-acetyl/-oxazolidine derivatives as antidotum substituted with heterocyclic group at the 5-position
EP0358190A3 (en) Polysiloxanes with sterically hindered moiety
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
DE69127791D1 (de) Diazabicyclononyl-Derivate als 5-HT3 Rezeptor Antagonisten
FI915825L (fi) Heterocykliska foereningar.
EP1029860A4 (en) BENZOFURANE DERIVATIVES
FI910750A7 (fi) Heterocykliska foereningar.
DE59005389D1 (de) Kompensationswaage.
DE69731556D1 (de) Fettemulsion, die ein xanthinderivat enthält
TR27090A (tr) Tetrahidropirimidin türevleri.
FI914910L (fi) Heterocykliska foereningar.
DE69003213D1 (de) Imidazol-Derivate als Histamin-H3-Agonisten.
ATE112567T1 (de) Imidazo(4,5-c>pyridine als paf antagonisten.
BR9201398A (pt) Emprego de oligouretanas com pesos moleculares de 5.000 ate 50.000
FI915125L (fi) Synergistiska kombinationer av idopropargylfoereningar med hexahydro-1,3,5-tris (2-hydroxietyl)-s -triazin foer kontroll av svamp- och bakterietillvaext i metallbearbetningsvaetskor.
MX9202909A (es) 4-[alquilcarbonil(substituidas)]-4,5-dihidro- y -4,5,6,7-tetrahidro-7-[fenil(substituidas)]pirazolo-[1,5-a]pirimidinas .
EP0884318A4 (en) CONDENSED PURINE DERIVATIVES
FI910748A7 (fi) Heterocykliska foereningar.
WO1997020814A1 (en) Propenone derivatives
EP0579836A4 (es)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559893

Country of ref document: ES